| Endovascular thrombectomy for acute ischemic stroke: a meta-analysis JH Badhiwala, F Nassiri, W Alhazzani, MH Selim, F Farrokhyar, J Spears, ... Jama 314 (17), 1832-1843, 2015 | 525 | 2015 |
| Endoglin (CD105): a review of its role in angiogenesis and tumor diagnosis, progression and therapy F Nassiri, MD Cusimano, BW Scheithauer, F Rotondo, A Fazio, ... Anticancer research 31 (6), 2283-2290, 2011 | 388 | 2011 |
| Degenerative cervical myelopathy—update and future directions JH Badhiwala, CS Ahuja, MA Akbar, CD Witiw, F Nassiri, JC Furlan, ... Nature Reviews Neurology 16 (2), 108-124, 2020 | 347 | 2020 |
| A clinically applicable integrative molecular classification of meningiomas F Nassiri, J Liu, V Patil, Y Mamatjan, JZ Wang, R Hugh-White, AM Macklin, ... Nature 597 (7874), 119-125, 2021 | 244 | 2021 |
| MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges A Mansouri, LD Hachem, S Mansouri, F Nassiri, NJ Laperriere, D Xia, ... Neuro-oncology 21 (2), 167-178, 2019 | 236 | 2019 |
| Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes F Nassiri, A Chakravarthy, S Feng, SY Shen, R Nejad, JA Zuccato, ... Nature medicine 26 (7), 1044-1047, 2020 | 215 | 2020 |
| DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management F Nassiri, Y Mamatjan, S Suppiah, JH Badhiwala, S Mansouri, S Karimi, ... Neuro-oncology 21 (7), 901-910, 2019 | 204 | 2019 |
| Atraumatic versus conventional lumbar puncture needles: a systematic review and meta-analysis S Nath, A Koziarz, JH Badhiwala, W Alhazzani, R Jaeschke, S Sharma, ... The Lancet 391 (10126), 1197-1204, 2018 | 178 | 2018 |
| Imaging and diagnostic advances for intracranial meningiomas RY Huang, WL Bi, B Griffith, TJ Kaufmann, C la Fougère, NO Schmidt, ... Neuro-oncology 21 (Supplement_1), i44-i61, 2019 | 148 | 2019 |
| Advances in multidisciplinary therapy for meningiomas PK Brastianos, E Galanis, N Butowski, JW Chan, IF Dunn, R Goldbrunner, ... Neuro-oncology 21 (Supplement_1), i18-i31, 2019 | 142 | 2019 |
| Molecular and translational advances in meningiomas S Suppiah, F Nassiri, WL Bi, IF Dunn, CO Hanemann, CM Horbinski, ... Neuro-oncology 21 (Supplement_1), i4-i17, 2019 | 123 | 2019 |
| Deep brain stimulation for Parkinson’s disease: meta-analysis of results of randomized trials at varying lengths of follow-up A Mansouri, S Taslimi, JH Badhiwala, CD Witiw, F Nassiri, VJJ Odekerken, ... Journal of neurosurgery 128 (4), 1199-1213, 2018 | 120 | 2018 |
| A molecularly integrated grade for meningioma J Driver, SE Hoffman, S Tavakol, E Woodward, EA Maury, V Bhave, ... Neuro-oncology 24 (5), 796-808, 2022 | 119 | 2022 |
| Bedside optic nerve ultrasonography for diagnosing increased intracranial pressure: a systematic review and meta-analysis A Koziarz, N Sne, F Kegel, S Nath, JH Badhiwala, F Nassiri, A Mansouri, ... Annals of internal medicine 171 (12), 896-905, 2019 | 105 | 2019 |
| Integrated models incorporating radiologic and radiomic features predict meningioma grade, local failure, and overall survival O Morin, WC Chen, F Nassiri, M Susko, ST Magill, HN Vasudevan, A Wu, ... Neuro-oncology advances 1 (1), vdz011, 2019 | 103 | 2019 |
| Minimum clinically important difference in SF-36 scores for use in degenerative cervical myelopathy JH Badhiwala, CD Witiw, F Nassiri, MA Akbar, B Jaja, JR Wilson, ... Spine 43 (21), E1260-E1266, 2018 | 87 | 2018 |
| Life after surgical resection of a meningioma: a prospective cross-sectional study evaluating health-related quality of life F Nassiri, B Price, A Shehab, K Au, MD Cusimano, MD Jenkinson, ... Neuro-oncology 21 (Supplement_1), i32-i43, 2019 | 86 | 2019 |
| Viral and other therapies for recurrent glioblastoma: is a 24-month durable response unusual? EA Chiocca, F Nassiri, J Wang, P Peruzzi, G Zadeh Neuro-oncology 21 (1), 14-25, 2019 | 83 | 2019 |
| Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial F Nassiri, V Patil, LS Yefet, O Singh, J Liu, RMA Dang, TN Yamaguchi, ... Nature medicine 29 (6), 1370-1378, 2023 | 82 | 2023 |
| Outcomes of surgically treated giant pituitary tumours MD Cusimano, P Kan, F Nassiri, J Anderson, J Goguen, I Vanek, ... Canadian journal of neurological sciences 39 (4), 446-457, 2012 | 81 | 2012 |
